LeydenLabs-SM-Dec2023-JPM-v03

January 8, 2024

Leyden Labs Selected to Present at 2024 J.P. Morgan Conference

Leyden Labs CEO Koenraad Wiedhaup will deliver a corporate presentation at the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024 in San Francisco, CA.

This will be the Company’s second year in a row presenting at the premier biotech investor conference. Presentation details are as follows:  

Leyden Labs Presentation at JPM
Date & time: Wednesday, January 10, 2024, at 5:00 p.m. PST
Location: Golden Gate Room of the Westin St. Francis Hotel

Koenraad will provide an overview of Leyden Labs’ unique expertise as masters of mucosal immunity, as well as the latest updates on the company’s programs targeting the nasal mucosa.

The presentation will not be webcast, but to request an update call with management, reach out to investors@leydenlabs.com.

LL-Blue

OUR NEW APPROACH  |  OUR TEAM  |  JOIN OUR MISSION   |  NEWS  |  CAREERS  

Contact

Media inquiries

Stay updated

Leyden Laboratories B.V.

Leiden Laboratory
Emmy Noetherweg 2
2333 BK  Leiden
The Netherlands


Leyden Laboratories Co.

Boston Laboratory
201 Dexter Avenue
Watertown
MA 02472
United States


Leyden Labs, S.L.

Granada Office
Avda. del Conocimiento 41.A210
Centro de Empresas
Parque Tecnológico de la Salud
18016 Granada
Spain


© Leyden Labs, 2023  |  Privacy Statement  |  Design by Ape to Zebra

Back to top Arrow